|
1
|
Ertugrul MS, Nadaroglu H, Nalci OB,
Hacimuftuoglu A and Alayli A: Preparation of CoS
nanoparticles-cisplatin bio-conjugates and investigation of their
effects on SH-SY5Y neuroblastoma cell line. Cytotechnology.
72:885–896. 2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
2
|
Ito R, Asami S, Kagawa S, Motohashi S,
Shichino H, Chin M, Yoshida Y, Nemoto N, Mugishima H and Suzuki T:
Usefulness of tyrosine hydroxylase mRNA for diagnosis and detection
of minimal residual disease in neuroblastoma. Biol Pharm Bull.
27:315–318. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qiao Y, Sunada NK, Hatada AE, Lange I,
Khutsishvili M, Alizade V, Atha D, Ko'omoa-Lange DL and Borris RP:
Potential anti-neuroblastoma agents from Juniperus oblonga. Biochem
Biophys Res Commun. 516:733–738. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pohl A, Erichsen M, Stehr M, Hubertus J,
Bergmann F, Kammer B and von Schweinitz D: Image-defined risk
factors correlate with surgical radicality and local recurrence in
patients with neuroblastoma. Klin Padiatr. 228:118–123.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Boyd JE, Parmley RT, Langevin AM and
Saldívar VA: Neuroblastoma presenting as acute monoblastic
leukemia. J Pediatr Hematol Oncol. 18:206–212. 1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zheng T, Ménard M and Weiss WA:
Neuroblastoma metastases: Leveraging the avian neural crest. Cancer
Cell. 32:395–397. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
London WB, Castleberry RP, Matthay KK,
Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM,
Reynolds CP and Cohn SL: Evidence for an age cutoff greater than
365 days for neuroblastoma risk group stratification in the
children's oncology group. J Clin Oncol. 23:6459–6465.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tumilowicz JJ, Nichols WW, Cholon JJ and
Greene AE: Definition of a continuous human cell line derived from
neuroblastoma. Cancer Res. 30:2110–2118. 1970.PubMed/NCBI
|
|
9
|
Imashuku S, Inui A, Nakamura T, Tanaka J
and Miyake S: Catecholamine metabolism in tissue culture cells of a
neuroblastoma. J Clin Endocrinol Metab. 36:931–936. 1973.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ji B, Maeda J, Higuchi M, Inoue K, Akita
H, Harashima H and Suhara T: Pharmacokinetics and brain uptake of
lactoferrin in rats. Life Sci. 78:851–855. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sriramoju B, Kanwar RK and Kanwar JR:
Lactoferrin induced neuronal differentiation: A boon for brain
tumours. Int J Dev Neurosci. 41:28–36. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Feng L, Li J, Qin L, Guo D, Ding H and
Deng D: Radioprotective effect of lactoferrin in mice exposed to
sublethal X-ray irradiation. Exp Ther Med. 16:3143–3148.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nishimura Y, Homma-Takeda S, Kim HS and
Kakuta I: Radioprotection of mice by lactoferrin against
irradiation with sublethal X-rays. J Radiat Res. 55:277–282.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wei YL, Xu JY, Zhang R, Zhang Z, Zhao L
and Qin LQ: Effects of lactoferrin on X-ray-induced intestinal
injury in Balb/C mice. Appl Radiat Isot. 146:72–77. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kato S: Under lithium carbonate
administration, nicotine triggers cell dysfunction in human
glioblastoma U-251MG cells, which is distinct from cotinine. Med
Int (Lond). 2(19)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kato S: Effects of platinum-coexisting
dopamine with X-ray irradiation upon human glioblastoma cell
proliferation. Hum Cell. 34:1653–1661. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zaatiti H, Abdallah J, Nasr Z, Khazen G,
Sandler A and Abou-Antoun TJ: Tumorigenic proteins upregulated in
the MYCN-amplified IMR-32 human neuroblastoma cells promote
proliferation and migration. Int J Oncol. 52:787–803.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tanimoto T, Tazawa H, Ieda T, Nouso H,
Tani M, Oyama T, Urata Y, Kagawa S, Noda T and Fujiwara T:
Elimination of MYCN-amplified neuroblastoma cells by
telomerase-targeted oncolytic virus via MYCN suppression. Mol Ther
Oncolytics. 18:14–23. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ishiyama M, Tominaga H, Shiga M, Sasamoto
K, Ohkura Y and Ueno K: A combined assay of cell viability and in
vitro cytotoxicity with a highly water-soluble tetrazolium salt,
neutral red and crystal violet. Biol Pharm Bull. 19:1518–1520.
1996.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Soh N, Ariyoshi T, Fukaminato T, Nakajima
H, Nakano K and Imato T: Swallow-tailed perylene derivative: A new
tool for fluorescent imaging of lipid hydroperoxides. Org Biomol
Chem. 5:3762–3768. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Wu L, Oshima T, Shan J, Sei H, Tomita T,
Ohda Y, Fukui H, Watari J and Miwa H: PAR-2 activation enhances
weak acid-induced ATP release through TRPV1 and ASIC sensitization
in human esophageal epithelial cells. Am J Physiol Gastrointest
Liver Physiol. 309:G695–G702. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Baehner RL and Nathan DG: Leukocyte
oxidase: Defective activity in chronic granulomatous disease.
Science. 155:835–836. 1967.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Choi HS, Kim JW, Cha YN and Kim C: A
quantitative nitroblue tetrazolium assay for determining
intracellular superoxide anion production in phagocytic cells. J
Immunoassay Immunochem. 27:31–44. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Elfinger M, Maucksch C and Rudolph C:
Characterization of lactoferrin as a targeting ligand for nonviral
gene delivery to airway epithelial cells. Biomaterials.
28:3448–3455. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Suzuki YA, Lopez V and Lönnerdal B:
Mammalian lactoferrin receptors: Structure and function. Cell Mol
Life Sci. 62:2560–2575. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bi C, Wang A, Chu Y, Liu S, Mu H, Liu W,
Wu Z, Sun K and Li Y: Intranasal delivery of rotigotine to the
brain with lactoferrin-modified PEG-PLGA nanoparticles for
Parkinson's disease treatment. Int J Nanomedicine. 11:6547–6559.
2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bannister JV, Bannister WH, Hill HA and
Thornalley PJ: Enhanced production of hydroxyl radicals by the
xanthine-xanthine oxidase reaction in the presence of lactoferrin.
Biochim Biophys Acta. 715:116–120. 1982.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Klebanoff SJ and Waltersdorph AM:
Prooxidant activity of transferrin and lactoferrin. J Exp Med.
172:1293–1303. 1990.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pietrantoni A, Ammendolia MG, Tinari A,
Siciliano R, Valenti P and Superti F: Bovine lactoferrin peptidic
fragments involved in inhibition of echovirus 6 in vitro infection.
Antiviral Res. 69:98–106. 2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chung TDY and Raymond KN: Lactoferrin: The
role of conformational changes in its iron binding and release. J
Am Chem Soc. 115:6765–6768. 1993.
|
|
31
|
Lorget F, Clough J, Oliveira M, Daury MC,
Sabokbar A and Offord E: Lactoferrin reduces in vitro osteoclast
differentiation and resorbing activity. Biochem Biophys Res Commun.
296:261–266. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gibbons JA, Kanwar JR and Kanwar RK:
Iron-free and iron-saturated bovine lactoferrin inhibit survivin
expression and differentially modulate apoptosis in breast cancer.
BMC Cancer. 15(425)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shoji H, Oguchi S, Shinohara K, Shimizu T
and Yamashiro Y: Effects of iron-unsaturated human lactoferrin on
hydrogen peroxide-induced oxidative damage in intestinal epithelial
cells. Pediatr Res. 61:89–92. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wakabayashi H, Matsumoto H, Hashimoto K,
Teraguchi S, Takase M and Hayasawa H: Inhibition of
iron/ascorbate-induced lipid peroxidation by an N-terminal peptide
of bovine lactoferrin and its acylated derivatives. Biosci
Biotechnol Biochem. 63:955–957. 1999.PubMed/NCBI View Article : Google Scholar
|
